MeSH tree: C06.552.241.519
An international clinical trial involving Birmingham Professor Phil Newsome identified a promising target for patients with non-alcoholic steatohepatitis (NASH), as reported in a paper published yesterday (Nov. 6) in Nature ...
Nov 7, 2023
0
53
A study spearheaded by Oregon State University has shown why certain polyunsaturated fatty acids work to combat a dangerous liver condition, opening a new avenue of drug research for a disease that currently has no FDA-approved ...
Oct 25, 2023
0
69
A growing body of research is drawing attention to health threats posed by human-made chemicals called "forever chemicals," which are targeted by a new California law requiring manufacturers to reduce their use in food packaging ...
Oct 18, 2023
0
61
A new study by QIMR Berghofer published in the Medical Journal of Australia has highlighted the critical need for doctors to be more vigilant with early detection and monitoring of liver complications in patients with diabetes ...
Oct 17, 2023
0
44
Fatty liver disease is exploding globally, affecting as many as 30% of people in Western countries. Apart from alcohol, obesity and diabetes are among the most dominant risk factors.
Oct 2, 2023
0
47
A severe form of fatty liver disease called nonalcoholic steatohepatitis (NASH) is the leading cause of liver transplantation, but there are few treatment options and currently no medications. In a new study, Yale researchers ...
Sep 27, 2023
0
85
Hepatic fibrosis occurs when scar tissue replaces damaged cells in the liver. Over time, accumulating scarring distorts the liver, interferes with its blood supply and may progressively lead to worsening consequences, from ...
Sep 27, 2023
0
42
A new research paper titled "Availability of living donor optimizes timing of liver transplant in high-risk waitlisted cirrhosis patients" has been published inAging.
Sep 26, 2023
0
32
Researchers have identified a mechanistic link between zinc levels in humans and the risk of type 2 diabetes and fatty liver disease.
Sep 26, 2023
0
414
A preclinical study led by Monash University has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer called hepatocellular carcinoma ...
Sep 14, 2023
0
77
